Skip to content

Guinea-Bissau vaccine trial ends without government approval

A researcher said the US-funded study will not proceed after failing to secure approval, following months of scrutiny over plans to delay hepatitis B vaccination for some babies.

Written by AI from 2 sources

Photo: Al Jazeera

  • Bandim Health Project researcher Frederik Schaltz-Buchholzer said the trial would not go ahead because it had not received the necessary government approval. Al Jazeera

  • The study was intended to compare vaccination at birth with vaccination at six weeks among about 14,000 babies, with researchers tracking health outcomes over five years. Al Jazeera

  • Health experts objected to withholding a vaccine recommended at birth by the WHO. Guinea-Bissau is considering bringing forward its planned introduction of the birth-dose vaccine. BBC NewsAl Jazeera